Zepbound is a subcutaneous injection ... you should learn about the medication transport laws in your destination country. Individual countries may have their own drug approval laws.

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a big revenue ... and services to both investment professionals and individual investors. These products and services ...

For instance, the Zepbound (tirzepatide ... from a single-dose vial. She has also heard of people injecting brand name GLP-1 weight loss medications from a pen into a vial, then drawing out ...

Mounjaro and Zepbound are part of a wave of diabetes and obesity medications known as GLP-1 receptor agonists that are soaring in popularity globally due to the amount of weight people lose while ...